Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients
about
Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantationRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationRegulatory T Cells in Kidney Transplantation: New Directions?Tolerance in liver transplantation: Biomarkers and clinical relevanceMethylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant PatientsCD45RA distinguishes CD4+CD25+CD127-/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus mediated inhibition of suppression.Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions.Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment.Immune profiling and cancer post transplantationMiR-152 may silence translation of CaMK II and induce spontaneous immune tolerance in mouse liver transplantation.Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.Essential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survival.Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation ToleranceLow-dose oral cholecalciferol is associated with higher numbers of Helios(+) and total Tregs than oral calcitriol in renal allograft recipients: an observational studySevere type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells.Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.Rapamycin regulates iTreg function through CD39 and Runx1 pathways.Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing.Monitoring alloimmune response in kidney transplantation.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Regulatory T-cell therapy in liver transplantation.Standardization, Evaluation, and Area-Under-Curve Analysis of Human and Murine Treg Suppressive FunctionSirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood TransplantationThe Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation.IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant.Regulatory T cell signatures in liver transplant recipients successfully weaned from immunosuppression: Getting from here to there.Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.Utility of IL-2 Complexes in Promoting the Survival of Murine Orthotopic Forelimb Vascularized Composite Allografts.Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms.Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: The Promise and the Stumbling Blocks.The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.
P2860
Q26751433-095AB935-ECFA-4211-926A-698F495B5F36Q26784460-CE953E11-F73C-4815-8420-7DED17B2FD3DQ26800184-067E0D49-2E84-4CE7-8A6E-A2DB5E26E30EQ28079523-29909628-D6D6-4148-8FA6-E6F7C600144FQ30360800-C3878AB8-BCDF-474E-933B-796DA7573F4AQ30489628-265832F3-4E1A-400C-BDF8-2594BBACCDFBQ33920146-29F109E3-26A6-4947-A800-B648481B0453Q34100538-CD133BCF-6EE6-46BD-92EF-E699FFB21237Q35050810-E4E4603D-65CE-404A-B629-47E32D20D1F6Q35227026-86281B0F-B518-465A-BEC3-BFFD2764DAC4Q35252405-DAC67C60-40FF-4279-B6EB-6287F72E1535Q35660071-C1F0B611-0F34-4021-9C2B-CB11B292A799Q35834994-A553DA30-7C97-4C90-ABC9-DC7030B6A615Q35903107-43E03C4A-4674-4E29-92AA-FD6379CF4F68Q36050928-4D7E309C-6171-4333-804F-7E510F125351Q36355454-D13B38D2-2867-4E7A-9489-785598489842Q36420758-12AF24EF-2CC3-4CBD-AE6F-121D3C184652Q37688473-FDBECE3B-64EF-4304-BD74-D4DBEB2CB4C2Q37706119-60FBA11A-6321-45EE-9101-F9D3B9051281Q38614123-4D7B0857-2D75-4A09-973F-242D7D909E60Q38619142-06BCCCE7-69DF-41C9-8145-E0F72578D47EQ38621446-0E572322-B8F9-4123-B64D-847CE0F30296Q38644612-44455F17-570B-4910-918D-765DC6EA27B2Q38849321-BF070738-AB04-4143-B191-73DC13382A48Q38918124-DAAD9C90-B2DD-4822-8CAC-91077CF5CE5AQ39279238-042CD9FA-D8D4-4DF7-8BF3-3E81D2011413Q39368910-AFA9CF0E-7545-4F78-B141-3220FAEC99CEQ40360050-50E4B507-C41A-4788-8E8E-A3E29AA9046FQ40577820-56DD2E9A-27DE-4CE7-93CF-DDE2AB21C3F0Q40731460-8075F619-9A65-45BB-B6A5-A508920192B8Q47099680-AA0565D1-610B-40E5-9850-57185BF100D4Q47146090-7590044F-8663-44DD-B3F9-FDB8B5339BC9Q47952891-4DFE8EB8-851B-4440-814C-B0CFDE7A7E6CQ48139031-AA37F6CF-5836-4F79-ABEB-7F233FD64F55Q48955797-6802E0D5-C0B1-4B8C-87BB-4F16FEA63CE7Q49618381-B58D96A9-CCC7-4A1A-8160-04EA0D960609Q49912213-BB355BB4-BAF6-4F06-AAF2-547EA871F2DEQ50632486-BB01D8CB-7487-4627-9CC1-1B7C6DCBC41FQ50796005-ECFC878A-6CD8-4842-B0C1-DC2D7F88E4C3Q52722715-EBCB77DC-E5F9-40E7-BCBB-17073A668BF4
P2860
Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Differing effects of rapamycin ...... d kidney transplant recipients
@ast
Differing effects of rapamycin ...... d kidney transplant recipients
@en
type
label
Differing effects of rapamycin ...... d kidney transplant recipients
@ast
Differing effects of rapamycin ...... d kidney transplant recipients
@en
prefLabel
Differing effects of rapamycin ...... d kidney transplant recipients
@ast
Differing effects of rapamycin ...... d kidney transplant recipients
@en
P2093
P2860
P1476
Differing effects of rapamycin ...... d kidney transplant recipients
@en
P2093
B M Kamath
J C Bucuvalas
J W Goebel
K E C Meyers
W W Hancock
P2860
P304
P356
10.1111/J.1600-6143.2012.04269.X
P407
P577
2012-09-20T00:00:00Z